Добавил:
Upload Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз: Предмет: Файл:
Rajesh_Chawla_-_ICU_Protocols_A_stepwise_approa[1].pdf
Скачиваний:
259
Добавлен:
13.03.2016
Размер:
9.49 Mб
Скачать

Syndromic Approach to Poisoning

69

 

Praveen Aggarwal

 

A 45-year-old male patient presented to the emergency department with altered mental status. According to the relatives, patient had ingested unknown liquid about half an hour ago. His pulse was 110/min, blood pressure was 90/69 mmHg, and pupils were small. His breath had a garlic-like odor. He had profuse sweating and incontinence of urine. Chest auscultation revealed bilateral rhonchi and crepitations.

Toxidromes are constellations of symptoms commonly encountered with certain drug classes. Evaluation of possible poisoning should include laboratory studies with complete metabolic profiles, electrolyte estimation, and liver and renal functions.

Step 1: Initial resuscitation

The initial approach in any emergency in an unconscious patient includes standard resuscitation with care of circulation, airway and breathing along with cervical spine immobilization (as the patient is in altered mental status, which could be due to trauma).

High-flow oxygen and intravenous fluids should be administered, and blood should be sent for urgent blood glucose, urea and electrolytes, and arterial blood gases.

Once the patient has been stabilized, the physician must consider how to minimize the bioavailability of toxin not yet absorbed, which antidotes (if any) to administer, and other measures to enhance elimination.

P. Aggarwal, M.D., D.N.B. (*)

Department of Emergency Medicine, All India Institute of Medical Sciences, New Delhi, India

e-mail: peekay_124@hotmail.com

R. Chawla and S. Todi (eds.), ICU Protocols: A stepwise approach,

553

DOI 10.1007/978-81-322-0535-7_69, © Springer India 2012

 

 

 

 

554

Table 69.1 Toxidromes

 

 

Toxidrome

Clinical features

Toxins

 

Cholinergic

Muscarinic features (DUMBELS):

Organophosphate and carbamate insecticides, nerve agents

 

 

D—diarrhea

(Soman, Tabun, sarin, VX), nicotine

 

 

U—urination

 

 

 

M—miosis

 

 

 

B—bronchorrhea, bronchoconstriction, bradycardia

 

 

 

E—emesis

 

 

 

L—lacrimation

 

 

 

S—salivation, sweating

 

 

 

Nicotinic features: mydriasis (uncommon), hypertension, muscle

 

 

 

weakness, tachycardia, fasciculations

 

 

 

CNS features: confusion, coma, convulsion

 

 

Anticholinergic

Constipation, retention of urine, mydriasis, dry lungs, dry and hot

Atropine, Datura, antihistamines, tricyclic antidepressants,

 

 

skin, dry mouth, hypertension, abnormal movements, tachycardia,

gyromitrin (found in a mushroom)

 

 

hyperthermia, hallucinations, delirium

 

 

Opioid

Coma, pinpoint pupils, respiratory depression, bradycardia,

Opiates (heroin, pethidine, morphine, dextropropoxyphene,

 

 

hypotension, hypothermia

loperamide, opium)

 

Sympathomimetic

Sweating, tremors, tachycardia, hypertension, hyperthermia,

Caffeine, theophylline, amphetamines, cocaine, phencyclidine

 

 

mydriasis, tachypnea, agitation, hyper-alert, seizures

(PCP), sedative/hypnotic withdrawal

 

Hallucinogenic

Hallucinations, depersonalization, agitation, hyperthermia,

Lysergic acid diethylamide, PCP, gamma-hydroxybutyrate

 

 

tachycardia, hypertension, nystagmus, mydriasis

(GHB), psilocybin (found in a mushroom)

 

Hypnotic–sedative

CNS depression, confusion, stupor, coma, bradycardia, hypotension,

Barbiturates, methaqualone, meprobamate

 

 

hypopnea, miosis, hyporeflexia

 

.P

 

 

Aggarwal

 

 

 

Table 69.2 Commonly encountered features and likely toxins

Features

Toxins/causes

Bradycardia

b-Blockers, cholinergic agents, clonidine, calcium channel

 

blockers, ethanol, digoxin, opiates, cholinergics

Tachycardia

Sympathomimetics (cocaine, caffeine, theophylline,

 

amphetamines), anticholinergics, reflex tachycardia due to

 

hypotension

Hypothermia

Carbon monoxide, opiates, hypoglycemic agents, alcohol,

 

sedative hypnotics

Hyperthermia

Nicotine, antihistamines, anticholinergics, sympathomi-

 

metics, aspirin, antidepressants, neuroleptic malignant

 

syndrome

Hypotension

Antihypertensive drugs, aluminum phosphide, cholin-

 

ergics, digoxin, antidepressants, phenothiazines, sedative

 

hypnotics, opiates

Hypertension

Cocaine, theophylline, sympathomimetics, caffeine,

 

anticholinergics, nicotine

Hypoventilation

Narcotics, sedative hypnotics, alcohol, GHB, botulism,

 

clonidine

Hyperventilation

Salicylates, amphetamines, theophylline, metabolic

 

acidosis (respiratory compensation)

Coma

Sedative hypnotics, opiates, alcohols, clonidine, carbon

 

monoxide, antidepressants

Mydriasis

Sympathomimetics, anticholinergics, antidepressants,

 

withdrawal (alcohol, opiate, sedative hypnotic)

Miosis

Organophosphates and carbamates, clonidine, opiates,

 

phenothiazines, sedative hypnotics

Seizures

Organophosphates, antidepressants, INH, sympathomimetics,

 

camphor, cocaine, amphetamines, theophylline, PCP,

 

withdrawal (ethanol, benzodiazepines), lithium, lidocaine,

 

lead, organochlorines (e.g., lindane, DDT), hypoglycemia

Breath odor

Garlic: organophosphate and carbamate insecticides,

 

aluminum phosphide, arsenic, phosphorus

 

Rotten eggs: hydrogen sulfide

 

Moth ball: naphthalene

 

Bitter almonds: cyanides

Prolonged QT interval on ECG

Carbamazepine, propoxyphene, quinidine, procainamide,

 

terfenadine, astemizole, tricyclic antidepressants, cocaine,

 

phenothiazines

Noncardiogenic pulmonary edema

Opiates, barbiturates, salicylates, irritant gases

on chest X-ray

 

Radio-opaque toxins on abdominal

Chloral hydrate, heavy metals (lead, arsenic, mercury),

X-ray (absence of radio-opaque

iron, phenothiazines, body packers, sustained-release

shadow does not exclude

medicines

poisoning by listed toxins)

 

Elevated anion gap (normal

Alcoholic ketoacidosis, cyanide, carbon monoxide, aspirin,

8–12 mEq/L) [Anion

toluene, methanol, ethylene glycol, metformin, uremia

gap = Na+–(HCO3 + Cl)]

(due to renal toxicity), iron, INH, lactic acidosis (due to

 

hypotension or hypoxia)

Elevated osmolar gap

Ethanol, methanol, ethylene glycol, isopropanol

(>10 mOsmol/L)

 

[Osmolar gap = measured

 

osmolality–calculated osmolarity]

 

[Calculated osmolarity =

 

2Na++BUN/2.8 + glucose/18]

 

556

P. Aggarwal

 

 

Step 2: Diagnosis by toxidromic approach

After initial stabilization, it is important to diagnose the type of poison ingested by the patient. This can be done by detailed history, examination, and simple laboratory tests, which include blood glucose, electrolytes, acid–base analysis, urine exam, and ECG. Based on history and examination, it may be possible to define a constellation of signs and symptoms or toxidromes, which may help in diagnosing the unknown poison. Common toxidromes are listed in Table 69.1. Antidotal and supportive treatment can then be provided.

Step 3: Diagnosis of the type of poison if clinical features not suggestive of a toxidrome

In many cases, a clear-cut toxidrome cannot be defined based on presenting clinical features. In such cases, prominent features may be used to diagnose the type of poison involved. Table 69.2 lists some of the commonly encountered features and the likely toxins.

Step 4: Decontamination, enhancing excretion, antidotal, and supportive treatment

Based on the likely poison, antidotal treatment should be instituted. However, supportive treatment is the most vital treatment in such patients. These topics have been discussed in Chap. 68.

Suggested Reading

1.Hill GE, Ogunnaike B, Nasir D. Patients presenting with acute toxin ingestion. Anesthesiol Clin. 2010;28:117–37.

This review of drug/toxin-induced injury discusses drug or toxin-induced pathology that the clinician may encounter and therapeutic approaches to these syndromes.

2.Frithsen IL, Simpson WM Jr. Recognition and management of acute medication poisoning. Am Fam Physician. 2010;81:316–23.

This article discusses overall management of acute medication poisoning.

3.Holstege CP, Dobmeier SG, Bechtel LK. Critical care toxicology. Emerg Med Clin North Am. 2008;26:715–39.

This article reviews the general approach and management of the critically poisoned patient. Complications of poisoning that may bring a rapid demise of the critically ill poisoned patient are highlighted and the management of those complications is discussed.

4.Tetrault JM, O’Connor PG. Substance abuse and withdrawal in the critical care setting. Crit Care Clin. 2008;24:767–88.

This article reviews the epidemiology of substance use in this population and the treatment of common withdrawal syndromes. The authors stress the importance of long-term planning as part of the overall treatment protocol beyond the acute presentation.

5.Erickson TB, Thompson TM, Lu JJ. An approach to the patient with an unknown overdose. Emerg Clin North Am. 2007;25:249–81.

This article reviews the management of unknown poisoning.

6.Koren G. A primer of paediatric toxic syndromes or ‘toxidromes’. Paediatr Child Health. 2007;12:457–9.

Соседние файлы в предмете [НЕСОРТИРОВАННОЕ]